LivaNova (LIVN) EBT Margin Growth (3y) (2019 - 2026)
LivaNova (LIVN) EBT Margin Growth (3y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.91 Bn | 193.31 Bn | 7.27 Bn | -429.00 |
| 2 | Stryker | 127.59 Bn | 124.11 Bn | 4.50 Bn | 574.00 |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 55.00 |
| 4 | Boston Scientific | 73.24 Bn | 72.70 Bn | 3.85 Bn | 764.00 |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 835.00 |
| 6 | Dexcom | 34.38 Bn | 32.44 Bn | 830.00 Mn | 598.00 |
| 7 | GE HealthCare Technologies | 33.96 Bn | 31.85 Bn | 2.18 Bn | 125.00 |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 631.00 |
| 9 | Steris | 23.08 Bn | 22.60 Bn | 684.20 Mn | 423.00 |
| 10 | LivaNova | 4.29 Bn | 3.77 Bn | 273.67 Mn | 293.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 293.00 |
| Mar 31, 2026 | 388.00 |
| Dec 31, 2025 | 533.00 |
| Sep 30, 2025 | 5,148.00 |
| Jun 30, 2025 | 198.00 |
| Mar 31, 2025 | -10,194.00 |
| Dec 31, 2024 | 1,840.00 |
| Sep 30, 2024 | 3,038.00 |
| Jun 30, 2024 | 2,664.00 |
| Mar 31, 2024 | -26.00 |
| Dec 31, 2023 | 8,150.00 |
| Sep 30, 2023 | 710.00 |
| Jun 30, 2023 | 1,369.00 |
| Mar 31, 2023 | 619.00 |
| Dec 31, 2022 | 5,547.00 |
| Sep 30, 2022 | -5,000.00 |
| Jun 30, 2022 | 2,030.00 |
| Mar 31, 2022 | 1,088.00 |
| Dec 31, 2021 | 9,321.00 |
| Sep 30, 2021 | -1,313.00 |